Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 7/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6803945 | 1.00 | RET (0.32) | RETKCNH2SCN5A | |
| SCHEMBL7099200 | 1.00 | RET (0.32) | RETKCNH2SCN5A | |
| SCHEMBL6795091 | 0.93 | KCNH2 (0.36) | RETKCNH2SCN5A | |
| SCHEMBL6795089 | 0.93 | KCNH2 (0.36) | RETKCNH2SCN5A | |
| SCHEMBL6795087 | 0.93 | KCNH2 (0.36) | RETKCNH2SCN5A | |
| SCHEMBL7509631 | 0.90 | PIM1 (0.35) | RET | |
| SCHEMBL8575755 | 0.85 | KCNH2 (0.33) | KCNH2SCN5A | |
| SCHEMBL14497194 | 0.85 | ACACB (0.37) | — | |
| SCHEMBL6802539 | 0.84 | KCNH2 (0.35) | KCNH2SCN5A | |
| SCHEMBL6802541 | 0.84 | KCNH2 (0.35) | KCNH2SCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029882-A1 | Antimicrobial quinolones, their compositions and uses | THE PROCTER & GAMBLE CO. | 2004-02-12 | — | — | US | disclosed |
| US-6645981-B2 | For therapy of microbial infection | THE PROCTER & GAMBLE COMPANY | 2003-11-11 | — | — | US | disclosed |
| EP-1341781-A1 | ANTIMICROBIAL QUINOLONES | THE PROCTER & GAMBLE COMPANY (US) | 2003-09-10 | — | — | EP | disclosed |
| US-20030008894-A1 | Antimicrobial quinolones, their compositions and uses | THE PROCTER & GAMBLE COMPANY | 2003-01-09 | — | — | US | disclosed |
| WO-2002048138-A1 | ANTIMICROBIAL QUINOLONES | THE PROCTER & GAMBLE COMPANY (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008894-A1 | Antimicrobial quinolones, their compositions and uses | QARS1, NQO2, Q6ZSR9 | RET 4857/4885KCNH2 1547/4885SCN5A 847/4885 |
| US-20040029882-A1 | Antimicrobial quinolones, their compositions and uses | QARS1, NQO2, Q6ZSR9 | RET 4857/4885KCNH2 1547/4885SCN5A 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.